Access to Innovative Treatments Act of 2026
Sponsored By: Representative Barragán, Nanette Diaz [D-CA-44]
Introduced
Summary
Creates a formal, time‑bound review process for adverse national coverage determinations for drugs and biologics. The bill would require set timelines, public comment, and transparency when Medicare denies or limits coverage that conflicts with a drug's approval or licensure, and it would stop older coverage rules from being applied to newly approved therapies in a way that restricts coverage.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Faster Medicare review for new drugs
If enacted, Medicare would get a faster, formal review for certain drug and biologic coverage decisions. The Secretary would have to start a review within 90 days after a request. A 30-day public comment period would begin when the review starts. The Secretary would issue a final decision within 120 days after the comment period ends. If the decision reverses or changes coverage, the Secretary would assign and implement a temporary or permanent code. Part D and MA-PD plans would not be allowed to use these specified NCDs to deny payment for covered drugs. The Secretary would not be able to apply an older NCD to a newly approved drug or biologic when doing so would limit coverage inconsistent with its approval or licensure. A new review of the same decision generally could not start for two years after a final decision. These changes would take effect upon enactment.
Sponsors & CoSponsors
Sponsor
Barragán, Nanette Diaz [D-CA-44]
CA • D
Cosponsors
Rep. Joyce, John [R-PA-13]
PA • R
Sponsored 6/24/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov